Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of generic amlodipine + valsartan 10/160 mg vs reference in healthy Thai volunteers (fasting)
TCTR20250909003Phase 1Not yet recruiting
- Sponsor
- Unison Laboratories
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of amlodipine and valsartan in hypertension (HTN) (2 arms), sponsored by Unison Laboratories. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
amlodipinevalsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on TCTR20250909003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250909003.